← Back to Events
GENERAL 11 DAYS AWAY
BBSW AI Solution
C-Path works with the FDA and European Medicine Agency (EMA) to accelerate the pace of medical product development while reducing related risks.
Coverage & Analysis
🇺🇸 Latest Americas News
All news → May 4 CRISPR Therapeutics' CASGEVY Reaches 60,000+ Eligible Patients Across 10 Countries Following Global Approvals May 4 Clene's CNM-Au8 Gets FDA Green Light for Accelerated Approval Pathway in ALS Treatment May 4 Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen in McCune-Albright Syndrome May 4 mBIOTA Elemental Diet Shows Promise for IBS Treatment in New Clinical Trial Data Presented at DDW 2026 May 4 Novartis Receives Health Canada Approval for Fabhalta Oral Treatment for C3G Patients